-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
CompileKe Ke
The lockdown and work interruption caused by the COVID-19 pandemic affect the global economy.
The foreign media BioSpace website pays attention to the annual salary of vaccine developer CEO:
Pfizer: Albert Bourla
Pfizer: Albert BourlaPfizer CEO Bora will make a net profit of US$21 million in 2020 because his company has cooperated with German BioNTech and became the first company to obtain emergency use authorization for the COVID-19 vaccine in the United States.
According to Bloomberg's analysis of Bora's compensation, the overall compensation plan for 2020 is an increase of 17% over his 2019 compensation plan.
The vaccine developed by Pfizer and BioNTech was approved in December last year and is 95% effective against the virus.
BioNTech: Ugur Sahin
BioNTech: Ugur SahinBioNTech CEO Sahin received a total salary of US$7.
According to Bloomberg News, Sahin is the sole shareholder of the German company, which controls 18% of BioNTech.
Moderna: St.
Moderna: St.
According to SEC documents, Bansell’s basic salary is $950,000.
Moderna is evaluating its vaccine for minors, as well as a vaccine for the emerging new strain of coronavirus.
Johnson & Johnson: Alex Gorsky
Johnson & Johnson: Alex GorskyGorski, chairman and CEO of life science giant Johnson & Johnson, received $25,365,800 in revenue in 2020.
Johnson & Johnson's single-dose vaccine was approved by the US FDA in March.
AstraZeneca: Pascal Soriot
AstraZeneca: Pascal SoriotIn 2020, Soriot received an annual salary of $21.
AstraZeneca’s vaccine is not authorized for use in the United States, but has been approved in Europe, South America and parts of Asia.
Article reference source:
CEOs of COVID-19 Vaccine Makers See Boost in Salaries